2' 3'-DIDEOXYADENOSINE 5'-TRIPHOSPHATE S

For research use only. Not for therapeutic Use.

  • CAT Number: M045583
  • CAS Number: 178451-61-1
  • Molecular Formula: C10H12N5Na4O11P3
  • Molecular Weight: 563.109543
  • Purity: ≥95%
Inquiry Now

<span style="color:#000000;"><span style="font-size: 12px; font-family: arial, helvetica, sans-serif;">2&#39; 3&#39;-DIDEOXYADENOSINE 5&#39;-TRIPHOSPHATE S(CAS&nbsp;178451-61-1;ddATP)&nbsp;&nbsp;is an <em>in vitro</em>&nbsp;inhibitor of reverse transcriptases from retroviruses, including HIV-1 and visna (K<span style="box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">i</span>s = 20 and 37 nM, respectively).It also blocks, <em>in vitro</em>, mammalian and bacterial DNA polymerases.&nbsp;ddATP, produced intracellularly by the phosphorylation of exogenously supplied 2&rsquo;,3&rsquo;-dideoxyadenosine, competes with dATP, resulting in chain termination.Because of this activity, dideoxynucleoside 5&rsquo;-triphosphates, including ddATP, are used to terminate chain extension produced by the Taq</span><font face="arial, helvetica, sans-serif">&nbsp;polymerase used in polymerase chain reactions.&nbsp;It is also an antagonist of the purinergic receptor P2X</font><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">2/3</span><font face="arial, helvetica, sans-serif">&nbsp;(pIC</font><span style="font-family: arial, helvetica, sans-serif; font-size: 12px; box-sizing: border-box; position: relative; line-height: 0; vertical-align: initial; bottom: -0.25em;">50</span><font face="arial, helvetica, sans-serif">&nbsp;= 6.5).</font></span>


Catalog Number M045583
CAS Number 178451-61-1
Molecular Formula C10H12N5Na4O11P3
Purity ≥95%
Storage Desiccate at -20C
Reference

1.<span style="font-family: Arial, sans-serif; font-size: 13px;">Boyle, Nicholas A., et al. &quot;Synthesis of 2 &lsquo;, 3 &lsquo;-Dideoxynucleoside 5 &lsquo;-&alpha;-P-Borano-&beta;, &gamma;-(difluoromethylene) triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Journal of medicinal chemistry</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;48.7 (2005): 2695-2700.<br />
2.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Frank, K. B., et al. &quot;Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2&#39;, 3&#39;-dideoxynucleosides.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Antimicrobial agents and chemotherapy</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;31.9 (1987): 1369-1374.<br />
3.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Ueno, Takamasa, Takuma Shirasaka, and Hiroaki Mitsuya. &quot;Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2&prime;, 3&prime;-dideoxynucleoside 5&prime;-triphosphates.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Journal of Biological Chemistry</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;270.40 (1995): 23605-23611.<br />
4.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Toji, Lorraine, and Seymour S. Cohen. &quot;The enzymatic termination of polydeoxynucleotides by 2&prime;, 3&prime;-dideoxyadenosine triphosphate.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Proceedings of the National Academy of Sciences</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;63.3 (1969): 871-877.<br />
5.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Toji, Lorraine, and Seymour S. Cohen. &quot;The enzymatic termination of polydeoxynucleotides by 2&prime;, 3&prime;-dideoxyadenosine triphosphate.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Proceedings of the National Academy of Sciences</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;63.3 (1969): 871-877.<br />
6.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Li, Ying, Vesselin Mitaxov, and Gabriel Waksman. &quot;Structure-based design of Taq DNA polymerases with improved properties of dideoxynucleotide incorporation.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Proceedings of the National Academy of Sciences</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;96.17 (1999): 9491-9496.<br />
7.</span><span style="font-family: Arial, sans-serif; font-size: 13px;">Jarvis, Michael F., et al. &quot;[3H] A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.&quot;&nbsp;</span><i style="font-family: Arial, sans-serif; font-size: 13px;">Journal of Pharmacology and Experimental Therapeutics</i><span style="font-family: Arial, sans-serif; font-size: 13px;">&nbsp;310.1 (2004): 407-416.</span>

Request a Quote